Atenolol as treatment for hepatic hemangiomas in a premature infant
Saved in:
Main Authors: | Samuel Der Sarkissian (Author), Ludi Ge (Author), Helen Yiling Sun (Author), Michelle K.Y. Chen (Author), Deshan Frank Sebaratnam (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
International heterogeneity in admission criteria and monitoring for the initiation of propranolol in infantile hemangioma
by: Samuel Antranig Der Sarkissian, FRACGP, et al.
Published: (2020) -
Propranolol or atenolol for the management of infantile hemangioma: Implications for long-term health
by: Mireille M. Hermans, MSc, et al.
Published: (2023) -
Oral atenolol versus propranolol in the treatment of infantile hemangioma: A systematic review and meta-analysis
by: Swapnil Annasaheb Pattanshetti, et al.
Published: (2022) -
The effect of atenolol and combination of atenolol and thiazide diuretic on the lipid profile in hypertensive patients
by: Jawna Khalid Mamdoh, et al.
Published: (2005) -
Fixed drug eruption induced by atenolol
by: H Belhadjali, et al.
Published: (2009)